An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Vrije Universiteit Amsterdam seeks a highly motivated researcher to explore GPCR pharmacology within the POLARIS doctoral network. The role focuses on developing cell-based assays, studying receptor signalling, and applying high-throughput screening to identify modulators for translational neuroscience research.
The position is embedded in the international POLARIS framework, offering rigorous training, secondments across EU institutions, and exposure to drug discovery at the interface of
You will use molecular receptor pharmacology techniques to investigate the orphan GPCR and its potential as a therapeutic target. Your work will include:
We are looking for a candidate with a Master's degree in pharmaceutical sciences, molecular neuroscience, biomedical sciences, medicinal chemistry or a comparable life sciences discipline. You bring:
Fluency in spoken and written English is essential.
Eligibility criteria
Important, strict eligibility criteria according to MARIE SKLODOWSKA CURIE programs apply to applicants:
You must not already hold a doctoral degree.At the time of the application deadline, you must have a Master's degree and must not have resided or carried out your main activity (work, studies, etc.) in the Netherlands for more than 12 months in the three years prior to the contract start date.You will participate in the network‑wide training programme of POLARIS, which includes (international) training activities and planned secondments with POLARIS partner organizations throughout the EU.A full‑time, 3‑year employment contract with Vrije Universiteit Amsterdam;
Salary, mobility allowance and benefits according to the applicable MSCA Doctoral Network and host‑organisation rules. More detailed information about the salary will follow; ;
Embedding in the international POLARIS doctoral training network;
Access to network‑wide training activities, secondments and transferable‑skills development;
A challenging and translational research project at the interface drug discovery, in vitro and in vivo neuroscience, rare disease biology;
A collaborative and entrepreneurial working environment;
An open and supportive team culture with opportunities for scientific and professional development.